Navigation Links


Roy Castle lung cancer research funding

3/12/2014

0

GOOD
 LIVERPOOL, UK 12 March 2014: The Roy Castle Lung Cancer Foundation has funded two new projects at the University of Liverpool which aim to improve survival rates for the UK's biggest cancer killer. Professor John Field, a Clinical Professor of Molecular Oncology, will receive 200,000 for the Liverpool Lung Project (LLP). The Roy Castle Lung Cancer Foundation has invested 20m over 23 years... [Comments]

Study: MLB pitchers don't regain performance level after Tommy John surgery

3/10/2014

0

GOOD
 DETROIT Major League Baseball players who undergo Tommy John surgery are less likely to regain the performance level they had before surgery, according to a Henry Ford Hospital study. The study is the first to show a link between the surgery and declining pitching performance at the profess... [Comments]Study: MLB pitchers don't regain performance level after Tommy John surgery

Patients with metabolic disorder may face higher complication risk following total joint replacement

3/10/2014

0

GOOD
 NEW ORLEANS─In a new study presented today at the 2014 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS), researchers found that total joint replacement patients with three or more metabolic syndrome risk factors were almost three times as likely to have complications within the first year after joint replacement. Metabolic syndrome is a combination of disorders,... [Comments]

Major League Baseball players win more games following Tommy John surgery

3/10/2014

0

GOOD
 NEW ORLEANS─Ulnar collateral ligament (UCLR) reconstruction, otherwise known as "Tommy John Surgery," is a procedure frequently performed on Major League Baseball (MLB) pitchers with a damaged or torn ulnar collateral ligament, a common elbow injury, typically from overuse. In the new study, "Rate of Return to Pitching and Performance after Tommy John Surgery in Major League Basebal... [Comments]

Total hip replacement surgery safe for nonagenarian patients

3/10/2014

0

GOOD
 NEW ORLEANS--As more Americans are living well into their 90s, the number of nonagenarian total hip replacement (THR) candidates continues to increase. In the study, "Total Hip Arthroplasty Proves Safe for Nonagenarian Patients," presented today at the at the 2014 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS), researchers reviewed patient characteristics and rates of po... [Comments]

Genetics may explain high-functioning senior athletes with hip abnormalities

3/10/2014

0

GOOD
 NEW ORLEANS─Genetics may explain why some senior athletes are high functioning despite having one or both hip abnormalities typically associated with early onset osteoarthritis (OA): developmental dislocation of the hip (dysplasia), a loose hip joint; or femoroacetabular impingement (FAI), a condition in which the hip bones are abnormally shaped, according to new research presented toda... [Comments]

Clinical trial identifies women most likely to benefit from vaginal mesh surgery

3/10/2014

0

GOOD
 Certain women with vaginal prolapse are most likely to benefit from undergoing vaginal mesh surgery, a technique that has become controversial and is the focus of numerous lawsuits. The findings, which are published early online in Ultrasound in Obstetrics & Gynecology , provide valuable information regarding who should and should not be considered candidates for the surgery. Vaginal prol... [Comments]

Novel vaccine trial design aims to answer key TB questions

3/10/2014

0

GOOD
 ROCKVILLE, MD, USA & CAPE TOWN, ZA, March 11, 2014 Aeras today announced the initiation of the first randomized, controlled tuberculosis (TB) vaccine trial designed to study prevention of Mycobacterium tuberculosis (Mtb) infection by vaccination. The Phase II study of the TB vaccine candidate, H4+IC31 (AERAS-404), will evaluate its safety, immunogenicity, and ability to prevent infection by... [Comments]

Prescriptions for opioids stabilizing after fivefold increase in 10-year span

3/10/2014

0

GOOD
 March 10, 2014 -- Death rates from opioids have been soaring in the U.S. since the 1990s. To support the appropriate use of these controlled substances and inform public health interventions to prevent drug abuse, most states have implemented a prescription drug monitoring program (PDMP). In a latest study, researchers at Columbia University's Mailman School of Public Health evaluated the impa... [Comments]

Claim that raw milk reduces lactose intolerance doesn't pass smell test, study finds

3/10/2014

0

GOOD
 STANFORD, Calif. Some sour news for lactose-intolerant people who hoped that raw milk might prove easier to stomach than pasteurized milk: A pilot study from the Stanford University School of Medicine shows little difference in digestibility between the two. The study was small it involved 16 participants but the lead investigator said the results were highly consistent among all... [Comments]

[next]
(Date:3/10/2014)... Certain women with vaginal prolapse are most likely ... technique that has become controversial and is the ... published early online in Ultrasound in Obstetrics ... should and should not be considered candidates for ... and the vaginal canal may protrude through the ...
(Date:3/10/2014)... opioids have been soaring in the U.S. since ... these controlled substances and inform public health interventions ... a prescription drug monitoring program (PDMP). In a ... of Public Health evaluated the impact of these ... 2007, annual rates of prescriptions for opioid analgesics ...
(Date:3/10/2014)... a broadly neutralizing HIV-1 antibody in a lupus ... conserved epitopes, representing a promising strategy for targeting ... of characteristics that suggest their development may be ... frequency is disproportionately low among patients with the ... Journal of Clinical Investigation , Mattia Bonsignori ...
(Date:3/10/2014)... AMHERST, Mass. Using a new approach to systematically ... a research team led by University of Massachusetts ... at Harvard Medical School, report that several have ... stem cells that could lead to tumor recurrence. ... chemotherapeutics that stop fast growing tumors have the ...
(Date:3/10/2014)... 10, 2014 If you,re having some drinks this St. ... you may end up on the business end of a ... you can beat it, think again; chemistry will land you ... video, we examine how your breath can get you busted ... available here: http://youtu.be/rvVzlg26bCM , Subscribe to the series ...
Breaking Medicine News(10 mins):Health News:Clinical trial identifies women most likely to benefit from vaginal mesh surgery 2Health News:Prescriptions for opioids stabilizing after fivefold increase in 10-year span 2Health News:JCI online ahead of print table of contents for March 10, 2014 2Health News:JCI online ahead of print table of contents for March 10, 2014 3Health News:JCI online ahead of print table of contents for March 10, 2014 4Health News:Several FDA-approved anti-cancer drugs induce stem cell tumors, perhaps thwarting therapy 2Health News:Several FDA-approved anti-cancer drugs induce stem cell tumors, perhaps thwarting therapy 3
... areas have denser breasts, making them more likely to ... at the annual meeting of the Radiological Society of ... pay more attention to having regular breast screening, said ... London Breast Institute at The Princess Grace Hospital in ...
... Cornell have created a modified chemotherapy that more effectively ... by adding a water-soluble polymer to the anti-cancer ... of Bioconjugate Chemistry. , This approach has the potential ... which may be sufficient to prevent the recurrence of ...
... COLUMBUS, Ohio, Nov. 26 Understand how ... intelligence. That,s the message behind,the new book ... Written by Timothy J. Walter, M.D., a ... Consolidation" (Lotus Magnus, August,2007, ISBN-13: 978-1604022377, $19.95) ...
... Joint collaboration will bring alternative herbicide tolerant systems and ... more choice for farmers ... Bayer CropScience AG, Mertec,LLC and M.S. Technologies LLC announced ... to jointly develop and commercialize,several innovative trait technology products ...
... Effective Marketing ... ... (VIHL, Vitasoy or "the Group") (HKEx: 0345),a Hong Kong- based manufacturer ... for the six months ended 30,September 2007 grew by 14.2%, to ...
... COVER: "Rudy,s Roots" (p. 30). Senior Writer Suzanne Smalley ... that,explain his moral code, which is at once rigid ... Giuliani,s outsized, complex adult personality,can be traced back to ... Long,Island, to a family of cops and hoods and ...
Cached Medicine News:Health News:City-dwelling women at greater risk for breast cancer 2Health News:New method of drug delivery more effective at reaching brain tumors 2Health News:Understand How Sleep Impacts Learning and Memory 2Health News:Bayer CropScience, Mertec and M.S. Technologies to Co-Develop New Soybean Trait Products 2Health News:Bayer CropScience, Mertec and M.S. Technologies to Co-Develop New Soybean Trait Products 3Health News:Vitasoy Recorded Healthy Sales Growth for 1H FY2007/2008 2Health News:Vitasoy Recorded Healthy Sales Growth for 1H FY2007/2008 3Health News:Vitasoy Recorded Healthy Sales Growth for 1H FY2007/2008 4Health News:Vitasoy Recorded Healthy Sales Growth for 1H FY2007/2008 5Health News:NEWSWEEK: Media Lead Sheet/December 3, 2007 Issue (on newsstands Monday, November 26). 2Health News:NEWSWEEK: Media Lead Sheet/December 3, 2007 Issue (on newsstands Monday, November 26). 3Health News:NEWSWEEK: Media Lead Sheet/December 3, 2007 Issue (on newsstands Monday, November 26). 4
...
... catheter is made of two probes which ... of sensor distance., ,VersaFlex disposable catheters ... ,Alpine's VersaFlex catheters are the smallest diameter ... and are the perfect combination of flexibility ...
... are efficient, economical, eliminate the risk ... comfort during the test period., ... been designed to use temperature correction ... calibration. The temperature correction factors for ...
FLEXILOG spare part....
Medicine Products:
(Date:1/15/2014)... 2014  According to Millennium Research Group (MRG), ... the United States and ... will expand moderately through 2022, with embolization particles ... increasing interest in drug-eluting beads (DEBs) and radioembolization ... of these markets. The European radioembolization ...
(Date:1/15/2014)... , Jan. 15, 2014  Valeant Pharmaceuticals International, Inc. ... that the applicable waiting period under the Hart-Scott-Rodino Antitrust ... previously announced tender offer by its indirect wholly-owned subsidiary, ... shares of common stock of Solta Medical, Inc. (NASDAQ: ... $2.92 per share, net to the seller in cash, ...
(Date:1/15/2014)... 15, 2014  Zafgen, Inc., a leading biopharmaceutical ... severely obese patients, today announced initial results from ... inhibitor of methionine aminopeptidase 2 (MetAP2), in patients ... genetic obesity.  These results showed improvements in body ... in body fat content and preserved lean body ...
Breaking Medicine Technology:US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4
... June 30 DURECT Corporation,(Nasdaq: DRRX ) ... Administration,(FDA) has granted to DURECT orphan drug designation ... post-herpetic neuralgia (PHN).,Bupivacaine is the active pharmaceutical ingredient ... is the first bupivacaine,product approved for PHN, under ...
... Iceland, June 30 At its annual R&D,event ... (Nasdaq: DCGN ) will,provide an update on ... the,commercial potential and marketing rollout for its growing ... genome,analysis service deCODEme(TM); recent progress in its drug ...
Cached Medicine Technology:ELADUR(TM) Development Update: DURECT Receives Orphan Drug Designation for Bupivacaine for Post-Herpetic Neuralgia 2ELADUR(TM) Development Update: DURECT Receives Orphan Drug Designation for Bupivacaine for Post-Herpetic Neuralgia 3Marketing of Diagnostics and deCODEme(TM), Recent Progress in Drug Development to be Highlighted at deCODE R&D Event 2Marketing of Diagnostics and deCODEme(TM), Recent Progress in Drug Development to be Highlighted at deCODE R&D Event 3